CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW 730.00
-70.00 (-8.75%)
Jul 28, 2026, 3:30 PM KST
CMG Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
| 108,130 | 274,691 | 245,561 | 334,730 | 298,618 | 590,292 | |
Market Cap Growth | -63.46% | 11.86% | -26.64% | 12.09% | -49.41% | 28.01% |
Enterprise Value | 169,848 | 305,502 | 239,371 | 285,069 | 182,746 | 466,997 |
Last Close Price | 730.00 | 1858.00 | 1768.00 | 2410.00 | 2150.00 | 4250.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
PE Ratio | - | - | 91.13 | 51.85 | - | 193.46 |
PS Ratio | 0.98 | 2.61 | 2.48 | 3.56 | 3.63 | 10.07 |
PB Ratio | 0.54 | 1.36 | 1.30 | 1.76 | 1.62 | 3.28 |
P/TBV Ratio | 0.55 | 1.40 | 1.33 | 1.82 | 1.64 | 3.30 |
P/OCF Ratio | - | - | 846.50 | 84.99 | 60.48 | 209.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | 1.54 | 2.90 | 2.42 | 3.04 | 2.22 | 7.97 |
EV/EBITDA Ratio | - | - | 54.82 | 50.96 | 34.71 | 99.16 |
EV/EBIT Ratio | - | - | 234.60 | 93.87 | 61.30 | 179.35 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | 0.44 | 0.36 | 0.42 | 0.14 | 0.04 | 0.00 |
Debt / EBITDA Ratio | - | - | 18.31 | 4.67 | 1.27 | 0.06 |
Net Debt / Equity Ratio | 0.31 | 0.23 | 0.02 | -0.22 | -0.38 | -0.66 |
Net Debt / EBITDA Ratio | -25.97 | -74.55 | 0.73 | -7.63 | -13.50 | -25.33 |
Net Debt / FCF Ratio | -1.22 | -1.12 | -0.11 | 5.06 | 20.64 | 22.29 |
Asset Turnover | 0.35 | 0.35 | 0.36 | 0.41 | - | 0.38 |
Inventory Turnover | 1.65 | 1.66 | 2.41 | 2.40 | - | 3.38 |
Quick Ratio | 0.83 | 0.60 | 1.46 | 3.80 | 4.58 | 15.12 |
Current Ratio | 1.25 | 0.92 | 1.81 | 4.72 | 6.17 | 16.18 |
Return on Equity (ROE) | -4.30% | -5.15% | 1.42% | 3.44% | - | 2.15% |
Return on Assets (ROA) | -1.06% | -0.76% | 0.23% | 0.83% | - | 1.06% |
Return on Invested Capital (ROIC) | -2.07% | -1.68% | 0.56% | 2.23% | 3.41% | 3.75% |
Return on Capital Employed (ROCE) | -2.20% | -1.80% | 0.40% | 1.40% | 1.60% | 1.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
Earnings Yield | -7.75% | -3.67% | 1.10% | 1.93% | -0.13% | 0.52% |
FCF Yield | -46.65% | -14.80% | -11.32% | -2.52% | -1.15% | -0.91% |
Payout Ratio | - | - | - | 0.45% | - | - |
Buyback Yield / Dilution | -0.91% | 73.24% | -288.03% | - | -14.27% | -11.63% |